###begin article-title 0
###xml 53 58 <span type="species:ncbi:9606">human</span>
The regulation of aggrecanase ADAMTS-4 expression in human Achilles tendon and tendon-derived cells
###end article-title 0
###begin p 1
This document may be redistributed and reused, subject to .
###end p 1
###begin title 2
Abstract
###end title 2
###begin p 3
###xml 296 301 <span type="species:ncbi:9606">human</span>
Several members of the ADAMTS (A Disintegrin And Metalloproteinase with ThromboSpondin motifs) family have been identified as aggrecanases, whose substrates include versican, the principal large proteoglycan in the tendon extracellular matrix. We have characterized the expression of ADAMTS-4 in human Achilles tendon and tendon-derived cells. ADAMTS-4 mRNA levels were higher in ruptured tendon compared with normal tendon or chronic painful tendinopathy. In tissue extracts probed by Western blotting, mature ADAMTS-4 (68 kDa) was detected only in ruptured tendons, while processed ADAMTS-4 (53 kDa) was detected also in chronic painful tendinopathy and in normal tendon. In cultured Achilles tendon cells, transforming growth factor-beta (TGF-beta) stimulated ADAMTS-4 mRNA expression (typically 20-fold after 24 h), while interleukin-1 induced a smaller, shorter-term stimulation which synergised markedly with that induced by TGF-beta. Increased levels of immunoreactive proteins consistent with mature and processed forms of ADAMTS-4 were detected in TGF-beta-stimulated cells. ADAMTS-4 mRNA was expressed at higher levels by tendon cells in collagen gels than in monolayer cultures. In contrast, the expression of ADAMTS-1 and -5 mRNA was lower in collagen gels compared with monolayers, and these mRNA showed smaller or opposite responses to growth factors and cytokines compared with that of ADAMTS-4 mRNA. We conclude that both ADAMTS-4 mRNA and ADAMTS-4 protein processing may be differentially regulated in normal and damaged tendons and that both the matrix environment and growth factors such as TGF-beta are potentially important factors controlling ADAMTS aggrecanase activities in tendon pathology.
###end p 3
###begin title 4
Abbreviations
###end title 4
###begin title 5
Keywords
###end title 5
###begin title 6
Introduction
###end title 6
###begin p 7
###xml 91 115 91 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib2" ref-type="bibr">&#197;str&#246;m and Rausing, 1995</xref>
###xml 181 203 181 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib53" ref-type="bibr">Waterston et al., 1997</xref>
###xml 449 576 449 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib21 bib19 bib31 bib29 bib37 bib38 bib36" ref-type="bibr">Kannus and Jozsa, 1991; Jarvinen et al., 1997; Movin et al., 1997; Maffulli et al., 2000; Riley et al., 1994, 2002; Riley, 2004</xref>
###xml 796 856 796 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib18 bib8 bib20" ref-type="bibr">Ireland et al., 2001; Corps et al., 2006; Jones et al., 2006</xref>
Tendons such as the Achilles are susceptible to chronic painful degenerative tendinopathy (Astrom and Rausing, 1995) and 'spontaneous' ruptures in the absence of previous symptoms (Waterston et al., 1997). A combination of histological, biochemical and molecular biological studies have indicated that there is a normal balance between the synthesis and degradation of tendon matrix components, which is disrupted in chronic or acute tendon damage (Kannus and Jozsa, 1991; Jarvinen et al., 1997; Movin et al., 1997; Maffulli et al., 2000; Riley et al., 1994, 2002; Riley, 2004). For example, there are multiple differences in gene expression in degenerate Achilles tendons compared to normal tendons, including the expression of extracellular matrix components and the enzymes that degrade them (Ireland et al., 2001; Corps et al., 2006; Jones et al., 2006).
###end p 7
###begin p 8
###xml 287 364 287 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib6 bib24 bib47 bib48" ref-type="bibr">Caterson et al., 2000; Kuno et al., 2000; Tang, 2001; Tortorella et al., 2001</xref>
###xml 424 465 424 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib43 bib54" ref-type="bibr">Sandy et al., 2001; Westling et al., 2004</xref>
###xml 535 607 535 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib39 bib5 bib52" ref-type="bibr">Robbins and Vogel, 1994; Benjamin and Ralphs, 1998; Waggett et al., 1998</xref>
###xml 683 734 683 734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib45 bib7" ref-type="bibr">Somerville et al., 2003; Collins-Racie et al., 2004</xref>
###xml 855 862 855 862 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 864 999 864 999 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib17 bib6 bib43 bib48 bib50 bib33" ref-type="bibr">Ilic et al., 1992; Caterson et al., 2000; Sandy et al., 2001; Tortorella et al., 2001; Vankemmelbeke et al., 2001; Patwari et al., 2005</xref>
###xml 1031 1070 1031 1070 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib35 bib42" ref-type="bibr">Rees et al., 2000; Samiric et al., 2004</xref>
###xml 1008 1014 <span type="species:ncbi:9913">bovine</span>
###xml 1108 1113 <span type="species:ncbi:9606">human</span>
Subfamily M12B of the metalloproteinases () comprises the ADAM (A Disintegrin And Metalloproteinase) and ADAMTS (A Disintegrin And Metalloproteinase with ThromboSpondin motifs) enzymes. ADAMTS-1, -4 and -5 have been characterised as aggrecanases which cleave aggrecan at specific sites (Caterson et al., 2000; Kuno et al., 2000; Tang, 2001; Tortorella et al., 2001). ADAMTS-1 and -4 have also been shown to cleave versican (Sandy et al., 2001; Westling et al., 2004), which is the principal large proteoglycan expressed in mid-tendon (Robbins and Vogel, 1994; Benjamin and Ralphs, 1998; Waggett et al., 1998). In addition, ADAMTS-8, -9 and -15 have been reported to cleave aggrecan (Somerville et al., 2003; Collins-Racie et al., 2004). Cleavage products consistent with ADAMTS-specific activity are observed in cartilage and synovium explant systems and in vivo (Ilic et al., 1992; Caterson et al., 2000; Sandy et al., 2001; Tortorella et al., 2001; Vankemmelbeke et al., 2001; Patwari et al., 2005) and in bovine flexor tendons (Rees et al., 2000; Samiric et al., 2004), but no data have been reported for human tendons.
###end p 8
###begin p 9
###xml 305 323 305 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib20" ref-type="bibr">Jones et al., 2006</xref>
###xml 648 666 648 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib20" ref-type="bibr">Jones et al., 2006</xref>
###xml 854 893 848 887 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib11 bib41" ref-type="bibr">Fenwick et al., 2001; Rolf et al., 2001</xref>
###xml 1113 1141 1107 1135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib25" ref-type="bibr">Lavagnino and Arnoczky, 2005</xref>
Using relative quantitative RT-PCR, we recently screened RNA samples from normal Achilles tendons and from individuals suffering either chronic tendon pain or spontaneous tendon rupture, for mRNA encoding all the known matrix metalloproteinases, ADAMTS and tissue inhibitors of metalloproteinases (TIMP) (Jones et al., 2006). In that screen, mRNA encoding the aggrecanases ADAMTS-1, -4, -5, -8, -9 and -15 were each detected. Of these mRNA, ADAMTS-1 mRNA was expressed at highest levels but showed little difference between normal, painful and ruptured tendons, while ADAMTS-4 mRNA showed the largest change, increasing 8-fold in ruptured tendons (Jones et al., 2006). Previous studies have highlighted the potential role of growth factors such as platelet-derived growth factor (PDGF) and transforming growth factor-beta (TGF-beta) in tendon pathology (Fenwick et al., 2001; Rolf et al., 2001), but little is known about their effect on aggrecanases. In addition, the mechanical environment acting on tenocytes cultured in a three-dimensional matrix has been shown to regulate some metalloproteinase activities (Lavagnino and Arnoczky, 2005). We have now tested the effects of growth factors on the regulation of ADAMTS-4 mRNA expression in Achilles tendon-derived cells in both monolayer and three-dimensional collagen gel cultures, and examined the expression of ADAMTS-4 protein in tendon tissues and cells.
###end p 9
###begin title 10
Results
###end title 10
###begin title 11
Expression of ADAMTS-4 mRNA and protein in tendon tissue samples
###end title 11
###begin p 12
###xml 76 94 76 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib20" ref-type="bibr">Jones et al., 2006</xref>
###xml 127 128 127 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 530 533 530 533 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;&#160;6</sup>
###xml 544 547 544 547 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;&#160;6</sup>
###xml 561 564 561 564 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;&#160;6</sup>
###xml 579 585 579 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig1" ref-type="fig">Fig. 1</xref>
###xml 666 667 666 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 679 680 679 680 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
We first confirmed the results of our previous screen of tendon tissue RNA (Jones et al., 2006), using an extended sample set (n = 14 per group) and a second, independently-derived, relative quantitative real-time RT-PCR primer-probe set, which was also used to determine ADAMTS-4 mRNA expression in the cell studies described below. ADAMTS-4 mRNA expression was detected in all tendon tissue samples. Normal, painful and ruptured tendon samples showed median values of ADAMTS-4 mRNA expression, relative to 18S rRNA, of 0.29 x 10- 6, 0.45 x 10- 6 and 3.07 x 10- 6 respectively (Fig. 1). The ruptured group differed significantly from the normal and painful groups (P < 0.01 and P < 0.05, respectively, by Wilcoxon rank sum test).
###end p 12
###begin p 13
###xml 147 163 147 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib13" ref-type="bibr">Gao et al., 2002</xref>
###xml 312 318 312 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 476 482 476 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 631 637 631 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 859 865 859 865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 1057 1063 1057 1063 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig2" ref-type="fig">Fig. 2</xref>
To assess the levels and processing of ADAMTS-4 protein in tendon tissue, we extracted samples using a neutral extraction buffer containing NP-40 (Gao et al., 2002). The major band detected by antibody AHP821GA (raised against a C-terminal domain peptide) was consistent with the mature 68 kDa form of ADAMTS-4 (Fig. 2A), while the major band detected by antibody PA1-1749 (raised against a catalytic domain peptide) was consistent with the processed 53 kDa form of ADAMTS-4 (Fig. 2B). The 68 kDa form of ADAMTS-4 was detected readily in ruptured tendon tissue, but little or none was detected in normal or painful tendon samples (Fig. 2A and data not shown). The 53 kDa form was detected in only three of the six samples of normal tendon tested, and to a variable extent in ruptured tendon samples, but was readily detected in all samples of painful tendon (Fig. 2B and data not shown). The detection of the two principal forms of ADAMTS-4 by these two antibodies was also observed in samples of cultured cells extracted using the NP-40-containing buffer (Fig. 2, lane marked cell).
###end p 13
###begin p 14
###xml 73 79 73 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 137 175 137 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib13 bib33" ref-type="bibr">Gao et al., 2002; Patwari et al., 2005</xref>
###xml 288 294 288 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 507 513 507 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 610 631 610 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib33" ref-type="bibr">Patwari et al. (2005)</xref>
###xml 904 910 904 910 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig2" ref-type="fig">Fig. 2</xref>
The preference of the PA1-1749 antibody for the 53 kDa form of ADAMTS-4 (Fig. 2B) is in agreement with studies using cartilage extracts (Gao et al., 2002; Patwari et al., 2005). Several additional faint bands were present across all lanes and may represent non-specific cross-reactivity (Fig. 2B); of these, a band of about 70 kDa prevented the unequivocal detection of the 68 kDa form of ADAMTS-4 by this antibody. The preference of the C-terminal domain antibody AHP821GA for the 68 kDa form of ADAMTS-4 (Fig. 2A) is similar to that of an antibody raised against the cysteine-rich region of ADAMTS-4 used by Patwari et al. (2005), although the precise epitope of AHP821GA within the cysteine-rich and spacer regions was not defined by the supplier. An additional band of between 55 and 60 kDa was detected by the antibody AHP821GA, principally in those samples with high expression of the 68 kDa form (Fig. 2A); this may represent an additional or alternative cleavage of the 68 kDa form in the spacer domain.
###end p 14
###begin title 15
Regulation of ADAMTS-4 mRNA expression in cultured tendon cells
###end title 15
###begin p 16
###xml 549 562 549 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig3 fig4" ref-type="fig">Figs. 3 and 4</xref>
###xml 723 729 723 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig3" ref-type="fig">Fig. 3</xref>
###xml 866 872 860 866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig3" ref-type="fig">Fig. 3</xref>
###xml 1010 1016 1004 1010 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig3" ref-type="fig">Fig. 3</xref>
Tendon cells in culture expressed each of ADAMTS-4, ADAMTS-1 and ADAMTS-5 mRNA. When the cells were rinsed into fresh serum-free medium, ADAMTS-4 mRNA levels in control cells showed a decrease during the first 48 h incubation, but subsequently showed only small (less than 2-fold) variations that were not consistent between experiments (data not shown). Growth factors and cytokines, added to the cells after 48 h adaptation to serum-free medium, stimulated the expression of ADAMTS-4 mRNA, with different characteristic time-course and magnitude (Figs. 3 and 4). Epidermal growth factor (EGF), fibroblast growth factor (FGF) or PDGF each induced small transient stimulations of ADAMTS-4 mRNA levels (about 3-fold at 6 h; Fig. 3A). Stimulation by interleukin-1beta (IL-1beta) followed a similar time-course but was greater in magnitude, reaching more than 10-fold (Fig. 3B), while stimulation by tumour necrosis factor (TNF) showed a significantly longer time-course, increasing between 6 and 24 h to 8-fold (Fig. 3A).
###end p 16
###begin p 17
###xml 121 134 118 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig3 fig4" ref-type="fig">Figs. 3 and 4</xref>
###xml 398 404 383 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig3" ref-type="fig">Fig. 3</xref>
###xml 682 688 655 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig3" ref-type="fig">Fig. 3</xref>
###xml 824 875 794 845 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib1 bib32" ref-type="bibr">Aspenberg and Forslund, 2000; Neuwirth et al., 2006</xref>
###xml 1075 1081 1042 1048 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig4" ref-type="fig">Fig. 4</xref>
The greatest stimulation of ADAMTS-4 mRNA expression by an individual growth factor or cytokine was induced by TGF-beta (Figs. 3 and 4). Detectable stimulation was obtained using 0.1 ng/ml TGF-beta and maximum stimulation (typically more than 20-fold) occurred after 24 h with 1-10 ng/ml TGF-beta. The stimulation of ADAMTS-4 mRNA by TGF-beta showed a marked synergy with that induced by IL-1beta (Fig. 3C); the combination of TGF-beta with IL-1beta induced substantially higher levels of ADAMTS-4 mRNA over the early period when IL-1beta was active individually (6-12 h), but by 24 h the combined stimulation was not reproducibly different from that achieved using TGF-beta alone (Fig. 3C). Other members of the TGF-beta superfamily, the bone morphogenetic proteins (BMP), have been implicated in tendon damage and repair (Aspenberg and Forslund, 2000; Neuwirth et al., 2006). We therefore tested BMP-2, BMP-7 and BMP-13 for effects on tendon cell mRNA expression. None of these BMP stimulated ADAMTS-4 mRNA expression, compared with 10- to 30-fold stimulation by TGF-beta (Fig. 4). However, both BMP-2 and BMP-13 stimulated the expression of aggrecan mRNA between 4- and 14-fold in the same cell samples (data not shown), indicating that active receptor signalling occurred over the dose range used.
###end p 17
###begin title 18
Expression of ADAMTS-4 protein in tendon cells
###end title 18
###begin p 19
###xml 247 260 247 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig2 fig5" ref-type="fig">Figs. 2 and 5</xref>
###xml 362 368 359 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig5" ref-type="fig">Fig. 5</xref>
###xml 741 747 726 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig3" ref-type="fig">Fig. 3</xref>
###xml 839 845 818 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig3" ref-type="fig">Fig. 3</xref>
###xml 1017 1037 993 1013 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib33" ref-type="bibr">Patwari et al., 2005</xref>
###xml 1048 1058 1024 1034 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="sec8" ref-type="sec">Discussion</xref>
Tendon cell protein extracts, prepared by lysis in the same NP-40-containing extraction buffer used for tendon tissue samples, contained ADAMTS-4-immunoreactive bands consistent with the mature (68 kDa) and processed (53 kDa) forms of the enzyme (Figs. 2 and 5). Both of these major forms showed an increase in intensity in cells treated for 24 h with TGF-beta (Fig. 5). In some experiments, the increase could be detected at 6 or 12 h, but by 48 h there was no reproducible difference in the intensity with/without TGF-beta (data not shown). In contrast to TGF-beta, IL-1beta did not reproducibly increase the levels of ADAMTS-4 proteins in cell extracts at 6-12 h (data not shown), i.e. at the time when IL-1beta stimulated ADAMTS-4 mRNA (Fig. 3B). This may be related to the lower level of mRNA stimulated by IL-1beta than by TGF-beta (Fig. 3B), but it is also possible that IL-1beta may also stimulate ADAMTS-4 protein turnover; it has been reported that IL-1 can alter ADAMTS-4 processing in cartilage explants (Patwari et al., 2005; see also Discussion).
###end p 19
###begin title 20
Comparison of cellular ADAMTS-1 and ADAMTS-5 mRNA expression with that of ADAMTS-4 mRNA
###end title 20
###begin p 21
###xml 21 39 21 39 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib20" ref-type="bibr">Jones et al., 2006</xref>
###xml 361 367 361 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig6" ref-type="fig">Fig. 6</xref>
###xml 401 407 401 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig3" ref-type="fig">Fig. 3</xref>
###xml 490 496 490 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig6" ref-type="fig">Fig. 6</xref>
###xml 564 565 564 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 590 591 590 591 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 634 640 634 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig6" ref-type="fig">Fig. 6</xref>
###xml 869 875 859 865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig6" ref-type="fig">Fig. 6</xref>
###xml 967 973 954 960 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig6" ref-type="fig">Fig. 6</xref>
###xml 1131 1137 1115 1121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig6" ref-type="fig">Fig. 6</xref>
###xml 1184 1190 1168 1174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig6" ref-type="fig">Fig. 6</xref>
We noted previously (Jones et al., 2006) that ADAMTS-1 mRNA expression showed little variation between tendon tissue sample groups while ADAMTS-5 mRNA decreased in painful tendons, thus contrasting with the pattern of ADAMTS-4 mRNA expression. In the present study, growth factors and cytokines had differential effects on ADAMTS-1 or ADAMTS-5 mRNA expression (Fig. 6) compared with that of ADAMTS-4 (Fig. 3). None of EGF, FGF and PDGF had a significant effect on ADAMTS-1 mRNA expression (Fig. 6A), but each induced significant decreases in ADAMTS-5 mRNA levels (P < 0.01, except for PDGF P < 0.05), which were maintained over 48 h (Fig. 6C). The addition of TNF or IL-1beta induced a transient decrease of ADAMTS-1 mRNA expression: a significant decrease at 6 h (64 +/- 4% by TNF, 55 +/- 5% by IL-1beta), was followed by a return to control levels or higher at 24 h (Fig. 6A,B). Similarly, TNF and IL-1beta induced a transient decrease of ADAMTS-1 mRNA expression (Fig. 6C,D). Finally, TGF-beta had contrasting effects on these two mRNA, inducing a small (2- to 3-fold) transient stimulation of ADAMTS-1 mRNA expression at 24 h (Fig. 6B) and a persistent decrease of ADAMTS-5 mRNA (Fig. 6D).
###end p 21
###begin title 22
Cellular ADAMTS mRNA expression in three-dimensional collagen gel cultures
###end title 22
###begin p 23
###xml 150 157 150 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl1" ref-type="table">Table 1</xref>
###xml 308 315 308 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl1" ref-type="table">Table 1</xref>
###xml 425 432 425 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl1" ref-type="table">Table 1</xref>
###xml 645 651 639 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig7" ref-type="fig">Fig. 7</xref>
When cells were placed in three-dimensional collagen gel cultures, ADAMTS-4 mRNA levels increased compared with those in parallel monolayer cultures (Table 1). In further contrast with ADAMTS-4, levels of both ADAMTS-1 and ADAMTS-5 mRNA were lower in cells in collagen gel cultures compared with monolayers (Table 1). These differences were established over the first 48 h of serum-free culture in collagen gel or monolayer (Table 1) and then persisted for up to 7 days without significant change (data not shown). Each of IL-1beta, TGF-beta and TNF were able to stimulate ADAMTS-4 mRNA expression above the raised basal level in collagen gels (Fig. 7), indicating that there was no general mechanistic interference between the cytokine-induced and gel-induced stimuli.
###end p 23
###begin title 24
Discussion
###end title 24
###begin p 25
###xml 189 201 189 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="sec1" ref-type="sec">Introduction</xref>
###xml 342 347 <span type="species:ncbi:9606">human</span>
Various studies have indicated that there is a balance between the synthesis and breakdown of matrix components in normal tendons, and that this balance is disrupted in tendinopathies (see Introduction). In this paper we have shown that mRNA encoding the aggrecanase ADAMTS-4 is regulated independently from ADAMTS-1 or ADAMTS-5 mRNA in both human Achilles tendon tissue samples and cultured tendon cells, and that mature and processed forms of ADAMTS-4 protein may be detected in tendon tissue and cellular extracts.
###end p 25
###begin p 26
###xml 90 242 90 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib12 bib4 bib34 bib22 bib30 bib51 bib9" ref-type="bibr">Flannery et al., 2000; Bau et al., 2002; Pratta et al., 2003; Kevorkian et al., 2004; Moulharat et al., 2004; Wachsmuth et al., 2004; Cross et al., 2005</xref>
###xml 806 992 803 989 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib6 bib48 bib50 bib23 bib55 bib49 bib51 bib33" ref-type="bibr">Caterson et al., 2000; Tortorella et al., 2001; Vankemmelbeke et al., 2001; Koshy et al., 2002; Yaminishi et al., 2002; Tzusaki et al., 2003; Wachsmuth et al., 2004; Patwari et al., 2005</xref>
###xml 1140 1160 1134 1154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib49" ref-type="bibr">Tzusaki et al., 2003</xref>
###xml 1254 1260 1245 1251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig3" ref-type="fig">Fig. 3</xref>
###xml 1413 1419 1401 1407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig6" ref-type="fig">Fig. 6</xref>
###xml 1025 1030 <span type="species:ncbi:9606">human</span>
Independent regulation of the ADAMTS aggrecanase genes has been noted in several tissues (Flannery et al., 2000; Bau et al., 2002; Pratta et al., 2003; Kevorkian et al., 2004; Moulharat et al., 2004; Wachsmuth et al., 2004; Cross et al., 2005). Our studies indicate that both the biomechanical environment and various cytokines and growth factors can contribute differential regulatory effects to ADAMTS gene expression in tendon cells. Each of EGF, FGF and PDGF increased ADAMTS-4 and decreased ADAMTS-5 mRNA expression respectively, which is the first demonstration of such effects of these growth factors. Several previous studies have described effects of IL-1beta on ADAMTS expression in cells or explants from different tissues, but with considerable variation in the degree of stimulation observed (Caterson et al., 2000; Tortorella et al., 2001; Vankemmelbeke et al., 2001; Koshy et al., 2002; Yaminishi et al., 2002; Tzusaki et al., 2003; Wachsmuth et al., 2004; Patwari et al., 2005). The only previous study using human tendon cells reported small, variable, effects of IL-1beta on ADAMTS-4 mRNA expression, measured after 16 h (Tzusaki et al., 2003): our work indicates that the optimum stimulation by IL-1beta occurs at an earlier time (6 h-Fig. 3). In contrast, there was a marked transient decrease in ADAMTS-1 and ADAMTS-5 mRNA expression after this time of treatment with either IL-1beta or TNF (Fig. 6).
###end p 26
###begin p 27
###xml 167 173 158 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig3" ref-type="fig">Fig. 3</xref>
###xml 319 325 307 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig6" ref-type="fig">Fig. 6</xref>
###xml 432 454 417 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib55" ref-type="bibr">Yaminishi et al., 2002</xref>
###xml 471 493 456 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib30" ref-type="bibr">Moulharat et al., 2004</xref>
###xml 523 541 508 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib9" ref-type="bibr">Cross et al., 2005</xref>
###xml 664 715 646 697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib1 bib32" ref-type="bibr">Aspenberg and Forslund, 2000; Neuwirth et al., 2006</xref>
###xml 821 843 800 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib44" ref-type="bibr">Shi and Massague, 2003</xref>
###xml 932 938 908 914 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig4" ref-type="fig">Fig. 4</xref>
TGF-beta induced the largest stimulation of ADAMTS-4 mRNA expression by any individual growth factor, and co-addition of TGF-beta with IL-1beta gave a marked synergy (Fig. 3), which has not been described previously. TGF-beta also induced a small stimulation of ADAMTS-1 mRNA expression but decreased that of ADAMTS-5 (Fig. 6). Contrasting effects of TGF-beta on different ADAMTS mRNA have been reported previously in synoviocytes (Yaminishi et al., 2002), chondrocytes (Moulharat et al., 2004) and prostate stromal cells (Cross et al., 2005). We also tested several BMP, members of the TGF-beta superfamily which have been implicated in tendon damage and repair (Aspenberg and Forslund, 2000; Neuwirth et al., 2006) and which act through related receptors to activate different SMAD transcription factors from TGF-beta (Shi and Massague, 2003). However, none of these BMP had effects similar to those of TGF-beta on ADAMTS-4 mRNA (Fig. 4). The activation of ADAMTS-4 expression thus shows a degree of specificity within the TGF-beta superfamily-SMAD signalling network.
###end p 27
###begin p 28
###xml 128 148 125 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib40" ref-type="bibr">Robbins et al., 1997</xref>
###xml 263 323 260 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib3 bib26 bib27" ref-type="bibr">Banes et al., 1999; Lavagnino et al., 2003; Lee et al., 2005</xref>
###xml 569 618 566 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib14 bib25" ref-type="bibr">Garvin et al., 2003; Lavagnino and Arnoczky, 2005</xref>
###xml 749 793 746 790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib10 bib16" ref-type="bibr">Ehrlich and Rittenberg, 2000; Grinnell, 2003</xref>
###xml 908 915 905 912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl1" ref-type="table">Table 1</xref>
###xml 1365 1372 1362 1369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl1" ref-type="table">Table 1</xref>
###xml 9 15 <span type="species:ncbi:9913">bovine</span>
In fetal bovine tendon, TGF-beta has been implicated in mediating the effects of compressive loading on matrix gene expression (Robbins et al., 1997). Indeed, mechanical loading of tendon is a potential regulatory mechanism for metalloproteinase gene expression (Banes et al., 1999; Lavagnino et al., 2003; Lee et al., 2005) that might complement the regulation of ADAMTS expression by growth factors and cytokines. Mechanotransduction signals are mediated, at least in part, by interactions of cells with the three-dimensional environment of the extracellular matrix (Garvin et al., 2003; Lavagnino and Arnoczky, 2005). We found that placing tendon cells in a three-dimensional collagen gel (a version of the fibroblast-populated collagen lattice: Ehrlich and Rittenberg, 2000; Grinnell, 2003) increased the expression of ADAMTS-4 mRNA relative to the monolayer and decreased that of ADAMTS-1 and ADAMTS-5 (Table 1). At least three factors may contribute to these effects (i) a specific interaction of the cells with collagen, (ii) a response to being in three dimensions rather than two, and (iii) a response to tension within the matrix. Although further work will be required to distinguish between these and other explanations, in initial experiments we have found no reproducible difference in ADAMTS expression between cells in anchored collagen gels (as in Table 1) and parallel gels that were free-floating, having been released from the culture dish (data not shown).
###end p 28
###begin p 29
###xml 175 286 175 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib6 bib12 bib55 bib34 bib33" ref-type="bibr">Caterson et al., 2000; Flannery et al., 2000; Yaminishi et al., 2002; Pratta et al., 2003; Patwari et al., 2005</xref>
###xml 592 605 592 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig1 fig2" ref-type="fig">Figs. 1 and 2</xref>
###xml 773 779 773 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 975 983 975 983 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1070 1076 1067 1073 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig5" ref-type="fig">Fig. 5</xref>
###xml 1586 1606 1577 1597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib33" ref-type="bibr">Patwari et al., 2005</xref>
Studies using explant and cell cultures from other tissues have shown increased aggrecanase activity under conditions where ADAMTS mRNA and/or protein levels are not altered (Caterson et al., 2000; Flannery et al., 2000; Yaminishi et al., 2002; Pratta et al., 2003; Patwari et al., 2005), indicating that both the translation of the mRNA and the processing of the ADAMTS proenzymes are subject to regulation. In tendon tissue extracts, we found that mature 68 kDa ADAMTS-4 immunoreactivity was principally detected in ruptured tendons, consistent with the elevation of mRNA in these samples (Figs. 1 and 2). However, in each clinical group, notably in painful tendinopathy, there were significant levels of the 53 kDa form detected preferentially by the PA1-1749 antibody (Fig. 2B). These results suggest that altered processing of ADAMTS-4 protein may occur between the different clinical groups. The principal change observed in the cellular expression of ADAMTS-4 protein in vitro was an increased level (of both main ADAMTS-4 forms) in cells stimulated by TGF-beta (Fig. 5). In some experiments, we observed a band of 40-45 kDa (reactive with the PA1-1749 antibody) in TCA-precipitated supernatant medium from 48-h -incubated cells (data not shown). This band was significantly smaller than the 53 kDa band present in cell extracts, and was elevated in cultures treated with either TGF-beta or IL-1beta. It may thus represent further processing and release of ADAMTS-4 from the cells in response to these cytokines, analogous to some of the effects reported in other model systems (Patwari et al., 2005).
###end p 29
###begin p 30
###xml 152 160 152 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 430 450 430 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib46" ref-type="bibr">Stanton et al., 2005</xref>
###xml 541 582 541 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib15 bib28" ref-type="bibr">Glasson et al., 2004; Little et al., 2005</xref>
###xml 351 355 <span type="species:ncbi:10090">mice</span>
###xml 413 418 <span type="species:ncbi:10090">mouse</span>
In conclusion, we have shown that ADAMTS-4 mRNA is regulated differentially from ADAMTS-1 and ADAMTS-5 mRNA in Achilles tendon and tendon-derived cells in vitro, and that active forms of ADAMTS-4 are present in the tendon tissues. The apparent functional redundancy of the ADAMTS aggrecanases is complex, as emphasised in studies of gene knockouts in mice, which indicate a major role for ADAMTS-5 aggrecanase in mouse cartilage (Stanton et al., 2005), but not ADAMTS-1 or ADAMTS-4, despite the fact that these are expressed in this tissue (Glasson et al., 2004; Little et al., 2005). However, none of these gene knockout studies addressed the question of ADAMTS aggrecanase function in tendon. Further studies will be required to determine the contribution of ADAMTS-4 to the observed changes in proteoglycans in tendinopathy.
###end p 30
###begin title 31
Experimental procedures
###end title 31
###begin title 32
Materials
###end title 32
###begin p 33
###xml 853 873 843 863 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib33" ref-type="bibr">Patwari et al., 2005</xref>
###xml 49 53 <span type="species:ncbi:9913">calf</span>
###xml 979 990 <span type="species:ncbi:3704">Horseradish</span>
Dulbecco's modified Eagle's medium (DMEM), fetal calf serum (FCS), antibiotics and oligonucleotide primers were obtained from Invitrogen (Paisley, UK). One-Step RT-PCR reagents and FAM-labelled oligonucleotide probes were obtained from Applied Biosystems (Warrington, UK) and Sigma-Genosys (Haverhill, UK). IL-1beta was a gift from Glaxo Wellcome (Stevenage, UK) and aliquots (1 mug/ml) were stored at - 70 degreesC. Other growth factors and cytokines were obtained from R&D Systems (Abingdon, Oxford, UK) or Insight Biotechnology (Wembley, UK) and were solubilised and stored according to the suppliers' instructions. Primary anti-ADAMTS-4 antibodies were as follows: antibody AHP821GA, raised against a C-terminal domain peptide, was from Serotec (Oxford, UK); antibody PA1-1749, raised against a catalytic domain peptide (also referred to as JSCVMA: Patwari et al., 2005) was from Affinity Bioreagents (Golden, CO, USA), obtained through Cambridge Bioscience (Cambridge, UK). Horseradish peroxidase-coupled secondary antibodies were from Dako (Ely, UK).
###end p 33
###begin title 34
Tendon specimens
###end title 34
###begin p 35
###xml 183 201 183 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib20" ref-type="bibr">Jones et al., 2006</xref>
###xml 104 112 <span type="species:ncbi:9606">patients</span>
###xml 310 318 <span type="species:ncbi:9606">patients</span>
All procedures had appropriate local ethical committee approval, and consent was obtained from informed patients. A detailed characterisation of the sample groups has been published (Jones et al., 2006). Normal Achilles tendon specimens were obtained from cadaver material, taken within 48 h of death, or from patients undergoing amputation of the leg for the removal of bone tumours, and showed normal histological appearance. Tissue from individuals suffering painful tendinopathy for more than 6 months was taken from the site of the lesion during surgery and showed abnormal histological appearance. Tissue from individuals undergoing repair of ruptured tendon, mostly within 48 h of the rupture occurring, was trimmed from the site of the rupture. Specimens were transported to the laboratory in ice-cold balanced salts solution, and were stored frozen at - 70 degreesC. The age of the individuals (14 per group) from which tissue was used for RNA analysis was as follows: normal tendon, range 20-97 years, median 55; painful tendinopathy, range 32-59 years, median 43; ruptured tendon, range 25-69 years, median 45. None of the ADAMTS mRNA expression showed a significant variation with age in this study (data not shown).
###end p 35
###begin title 36
RNA isolation from tendon tissue samples
###end title 36
###begin p 37
###xml 107 127 107 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib18" ref-type="bibr">Ireland et al., 2001</xref>
###xml 547 587 546 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib18 bib20" ref-type="bibr">Ireland et al., 2001; Jones et al., 2006</xref>
###xml 821 864 820 863 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib2 bib20" ref-type="bibr">&#197;str&#246;m and Rausing 1995; Jones et al., 2006</xref>
###xml 489 494 <span type="species:ncbi:9606">human</span>
Total RNA was isolated from frozen tissue samples by a modified Tri-Spin protocol as described previously (Ireland et al., 2001) and was finally resuspended in 100 mul water. The concentration of RNA was estimated using a NanoDrop spectrophotometer (NanoDrop Technologies, Delaware, USA; courtesy of Prof. D.E. Neal's group at the Hutchison/MRC Research Centre, Cambridge). The majority of samples yielded between 20 and 70 ng RNA/mg wet weight, consistent with our previous experience of human tendon samples, most of which have low cellularity (Ireland et al., 2001; Jones et al., 2006). Five of the painful tendinopathy samples and three of the ruptured tendon samples gave RNA yields between 85 and 330 ng/mg, significantly above the normal range, consistent with an increase in cellularity observed in such samples (Astrom and Rausing 1995; Jones et al., 2006). The RNA was diluted to 1 ng/mul, and stored at - 70 degreesC as aliquots which were thawed once only. Samples from each group gave well-defined bands of 28S and 18S rRNA on 1.2% (w/v) agarose gels, with no evidence of significant degradation. ADAMTS-4 mRNA was assayed by One-Step relative quantitative real-time RT-PCR, normalised to 18S rRNA, as described below.
###end p 37
###begin title 38
Protein extracts and Western blotting
###end title 38
###begin p 39
###xml 157 173 157 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib13" ref-type="bibr">Gao et al., 2002</xref>
###xml 1143 1149 1122 1128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig2" ref-type="fig">Fig. 2</xref>
Protein was extracted from tendon tissue samples by homogenisation in 3 volumes of extraction buffer (50 mM Tris pH 7.0, 150 mM NaCl, 5 mM EDTA, 0.5% NP-40 (Gao et al., 2002) with added protease inhibitors: 10 muM E64, 1.5 muM pepstatin A and 1 mM PMSF) followed by incubation overnight at 4 degreesC and centrifugation (14,000 g, 4 degreesC, 15 min). The protein content of the clarified extracts was determined, and 50 mug of each extract was precipitated using trichloroacetic acid (3.3% w/v), washed with acetone, dried and redissolved in 100 mul of protein gel sample buffer. Ten mug (20 mul) of extract was boiled with gel sample buffer for 3 min and subjected to SDS-PAGE under reducing conditions, using a 4% (w/v) polyacrylamide stacking gel with a 10% (w/v) polyacrylamide gel. The proteins were electroblotted onto PVDF membranes, which were then blocked, incubated with primary antibodies, washed, incubated with secondary antibodies, washed again, incubated with CDP-Star (Roche, Lewes, UK) and exposed to film, all using standard methods. An aliquot of an extract from TGF-beta-treated tendon cells was included on each gel (see Fig. 2, lanes marked cell) to act as a standard for comparison of the autoradiographs.
###end p 39
###begin title 40
Culture of tendon cells
###end title 40
###begin p 41
###xml 441 442 441 442 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 387 395 <span type="species:ncbi:9606">patients</span>
Tendon cells were isolated by outgrowth from explant cultures established from mid-tendon samples taken during surgery for chronic tendinopathy. Cells were maintained and passaged in DMEM containing 10% (v/v) FCS, penicillin, streptomycin and 25 mM HEPES, and were used between passages 4 and 10. Each experiment was performed separately using cells derived from at least three separate patients with similar results. Cells were seeded at 105/well in 6-well plates and were incubated for 3 days before the experiment. They were rinsed with serum-free DMEM containing insulin, transferrin and selenium and were incubated in the same medium for 48 h. Cytokines and growth factors were then added to the medium and equivalent additions of vehicle were made to control wells. After a further incubation (6-48 h), the cells were rinsed with balanced salts solution and solubilised in TRI-Reagent (Sigma; 1 ml/well). RNA was isolated from the TRI-Reagent extracts by phenol-chloroform phase separation followed by precipitation with isopropanol and ethanol. Proteins were extracted from parallel wells using the NP-40-containing buffer described above, and the extracts were clarified by centrifugation (14,000 g, 4 degreesC, 15 min) and prepared for Western blotting as described above.
###end p 41
###begin p 42
###xml 88 89 88 89 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 362 363 362 363 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 676 677 676 677 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 132 135 <span type="species:ncbi:10116">Rat</span>
Cells for collagen gel cultures were centrifuged (5 min at 300 g), resuspended at 2 x 106/ml in serum-free DMEM, and placed on ice. Rat-tail Type I collagen solution (in 0.6% acetic acid; First-Link, Birmingham, UK) was mixed on ice with 10 x DMEM, neutralised using NaOH, and mixed thoroughly with the cell suspension. Aliquots of the mixture, containing 1 x 105 cells in 0.5 ml of collagen (1.6 mg/ml) in DMEM, were placed in the wells of a 24-well plate. The collagen was allowed to set at room temperature (about 20 min) before being overlaid with 1 ml of DMEM. Cells for parallel monolayer cultures were centrifuged, resuspended and plated in neighbouring wells at 2 x 104 cells/well in DMEM containing 10% FCS to promote attachment. After attachment, the cells were rinsed and incubated in serum-free DMEM, and monolayer and gel cultures were incubated for a further 48 h before harvest in TRI-Reagent (1 ml/well for monolayers and 2 ml/well for collagen gels). RNA was isolated from the TRI-Reagent extracts as described above.
###end p 42
###begin title 43
Relative quantitative real-time RT-PCR
###end title 43
###begin p 44
###xml 211 251 211 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib18 bib8" ref-type="bibr">Ireland et al., 2001; Corps et al., 2006</xref>
###xml 936 939 936 939 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F&#160;=</label>
###xml 939 956 939 956 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="46">CCAGTGACCGGGATGCA</p>
###xml 936 956 936 956 <list-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><label>F&#160;=</label><p textid="46">CCAGTGACCGGGATGCA</p></list-item>
###xml 956 959 956 959 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R&#160;=</label>
###xml 959 979 959 979 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="47">ACATGTCTGGGACCCACACA</p>
###xml 956 979 956 979 <list-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><label>R&#160;=</label><p textid="47">ACATGTCTGGGACCCACACA</p></list-item>
###xml 979 982 979 982 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P&#160;=</label>
###xml 982 1015 982 1015 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="48">TATGACACAGCAATTCTTTTCACCAGACAGGAC</p>
###xml 979 1015 979 1015 <list-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><label>P&#160;=</label><p textid="48">TATGACACAGCAATTCTTTTCACCAGACAGGAC</p></list-item>
###xml 936 1015 936 1015 <list xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" list-type="simple"><list-item><label>F&#160;=</label><p textid="46">CCAGTGACCGGGATGCA</p></list-item><list-item><label>R&#160;=</label><p textid="47">ACATGTCTGGGACCCACACA</p></list-item><list-item><label>P&#160;=</label><p textid="48">TATGACACAGCAATTCTTTTCACCAGACAGGAC</p></list-item></list>
###xml 917 1015 917 1015 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="45">ADAMTS-1 (<ext-link xlink:href="NM_006988" ext-link-type="gen">NM_006988</ext-link>; 77&#160;bp):<list list-type="simple"><list-item><label>F&#160;=</label><p textid="46">CCAGTGACCGGGATGCA</p></list-item><list-item><label>R&#160;=</label><p textid="47">ACATGTCTGGGACCCACACA</p></list-item><list-item><label>P&#160;=</label><p textid="48">TATGACACAGCAATTCTTTTCACCAGACAGGAC</p></list-item></list></p>
###xml 917 1015 917 1015 <list-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="45">ADAMTS-1 (<ext-link xlink:href="NM_006988" ext-link-type="gen">NM_006988</ext-link>; 77&#160;bp):<list list-type="simple"><list-item><label>F&#160;=</label><p textid="46">CCAGTGACCGGGATGCA</p></list-item><list-item><label>R&#160;=</label><p textid="47">ACATGTCTGGGACCCACACA</p></list-item><list-item><label>P&#160;=</label><p textid="48">TATGACACAGCAATTCTTTTCACCAGACAGGAC</p></list-item></list></p></list-item>
###xml 1034 1037 1034 1037 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F&#160;=</label>
###xml 1037 1057 1037 1057 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="50">GCAACGTCAAGGCTCCTCTT</p>
###xml 1034 1057 1034 1057 <list-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><label>F&#160;=</label><p textid="50">GCAACGTCAAGGCTCCTCTT</p></list-item>
###xml 1057 1060 1057 1060 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R&#160;=</label>
###xml 1060 1085 1060 1085 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="51">CTCCACAAATCTACTCAGTGAAGCA</p>
###xml 1057 1085 1057 1085 <list-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><label>R&#160;=</label><p textid="51">CTCCACAAATCTACTCAGTGAAGCA</p></list-item>
###xml 1085 1088 1085 1088 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P&#160;=</label>
###xml 1088 1110 1088 1110 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="52">AGACCCCGAAGAGCCAAGCGCT</p>
###xml 1085 1110 1085 1110 <list-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><label>P&#160;=</label><p textid="52">AGACCCCGAAGAGCCAAGCGCT</p></list-item>
###xml 1034 1110 1034 1110 <list xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" list-type="simple"><list-item><label>F&#160;=</label><p textid="50">GCAACGTCAAGGCTCCTCTT</p></list-item><list-item><label>R&#160;=</label><p textid="51">CTCCACAAATCTACTCAGTGAAGCA</p></list-item><list-item><label>P&#160;=</label><p textid="52">AGACCCCGAAGAGCCAAGCGCT</p></list-item></list>
###xml 1015 1110 1015 1110 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="49">ADAMTS-4 (<ext-link xlink:href="NM_005099" ext-link-type="gen">NM_005099</ext-link>; 83&#160;bp):<list list-type="simple"><list-item><label>F&#160;=</label><p textid="50">GCAACGTCAAGGCTCCTCTT</p></list-item><list-item><label>R&#160;=</label><p textid="51">CTCCACAAATCTACTCAGTGAAGCA</p></list-item><list-item><label>P&#160;=</label><p textid="52">AGACCCCGAAGAGCCAAGCGCT</p></list-item></list></p>
###xml 1015 1110 1015 1110 <list-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="49">ADAMTS-4 (<ext-link xlink:href="NM_005099" ext-link-type="gen">NM_005099</ext-link>; 83&#160;bp):<list list-type="simple"><list-item><label>F&#160;=</label><p textid="50">GCAACGTCAAGGCTCCTCTT</p></list-item><list-item><label>R&#160;=</label><p textid="51">CTCCACAAATCTACTCAGTGAAGCA</p></list-item><list-item><label>P&#160;=</label><p textid="52">AGACCCCGAAGAGCCAAGCGCT</p></list-item></list></p></list-item>
###xml 1129 1132 1129 1132 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F&#160;=</label>
###xml 1132 1155 1132 1155 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="54">AGGAGCACTACGATGCAGCTATC</p>
###xml 1129 1155 1129 1155 <list-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><label>F&#160;=</label><p textid="54">AGGAGCACTACGATGCAGCTATC</p></list-item>
###xml 1155 1158 1155 1158 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R&#160;=</label>
###xml 1158 1178 1158 1178 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="55">CCCAGGGTGTCACATGAATG</p>
###xml 1155 1178 1155 1178 <list-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><label>R&#160;=</label><p textid="55">CCCAGGGTGTCACATGAATG</p></list-item>
###xml 1178 1181 1178 1181 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P&#160;=</label>
###xml 1181 1209 1181 1209 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="56">TGCCCACATAAATCCTCCCGAGTAAACA</p>
###xml 1178 1209 1178 1209 <list-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><label>P&#160;=</label><p textid="56">TGCCCACATAAATCCTCCCGAGTAAACA</p></list-item>
###xml 1129 1209 1129 1209 <list xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" list-type="simple"><list-item><label>F&#160;=</label><p textid="54">AGGAGCACTACGATGCAGCTATC</p></list-item><list-item><label>R&#160;=</label><p textid="55">CCCAGGGTGTCACATGAATG</p></list-item><list-item><label>P&#160;=</label><p textid="56">TGCCCACATAAATCCTCCCGAGTAAACA</p></list-item></list>
###xml 1110 1209 1110 1209 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="53">ADAMTS-5 (<ext-link xlink:href="XM_047802" ext-link-type="gen">XM_047802</ext-link>; 73&#160;bp):<list list-type="simple"><list-item><label>F&#160;=</label><p textid="54">AGGAGCACTACGATGCAGCTATC</p></list-item><list-item><label>R&#160;=</label><p textid="55">CCCAGGGTGTCACATGAATG</p></list-item><list-item><label>P&#160;=</label><p textid="56">TGCCCACATAAATCCTCCCGAGTAAACA</p></list-item></list></p>
###xml 1110 1209 1110 1209 <list-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="53">ADAMTS-5 (<ext-link xlink:href="XM_047802" ext-link-type="gen">XM_047802</ext-link>; 73&#160;bp):<list list-type="simple"><list-item><label>F&#160;=</label><p textid="54">AGGAGCACTACGATGCAGCTATC</p></list-item><list-item><label>R&#160;=</label><p textid="55">CCCAGGGTGTCACATGAATG</p></list-item><list-item><label>P&#160;=</label><p textid="56">TGCCCACATAAATCCTCCCGAGTAAACA</p></list-item></list></p></list-item>
###xml 917 1209 917 1209 <list xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" list-type="simple"><list-item><p textid="45">ADAMTS-1 (<ext-link xlink:href="NM_006988" ext-link-type="gen">NM_006988</ext-link>; 77&#160;bp):<list list-type="simple"><list-item><label>F&#160;=</label><p textid="46">CCAGTGACCGGGATGCA</p></list-item><list-item><label>R&#160;=</label><p textid="47">ACATGTCTGGGACCCACACA</p></list-item><list-item><label>P&#160;=</label><p textid="48">TATGACACAGCAATTCTTTTCACCAGACAGGAC</p></list-item></list></p></list-item><list-item><p textid="49">ADAMTS-4 (<ext-link xlink:href="NM_005099" ext-link-type="gen">NM_005099</ext-link>; 83&#160;bp):<list list-type="simple"><list-item><label>F&#160;=</label><p textid="50">GCAACGTCAAGGCTCCTCTT</p></list-item><list-item><label>R&#160;=</label><p textid="51">CTCCACAAATCTACTCAGTGAAGCA</p></list-item><list-item><label>P&#160;=</label><p textid="52">AGACCCCGAAGAGCCAAGCGCT</p></list-item></list></p></list-item><list-item><p textid="53">ADAMTS-5 (<ext-link xlink:href="XM_047802" ext-link-type="gen">XM_047802</ext-link>; 73&#160;bp):<list list-type="simple"><list-item><label>F&#160;=</label><p textid="54">AGGAGCACTACGATGCAGCTATC</p></list-item><list-item><label>R&#160;=</label><p textid="55">CCCAGGGTGTCACATGAATG</p></list-item><list-item><label>P&#160;=</label><p textid="56">TGCCCACATAAATCCTCCCGAGTAAACA</p></list-item></list></p></list-item></list>
One-Step real-time RT-PCR reactions were performed in a GeneAmp 5700 (Applied Biosystems). The primers and probe for glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and 18S rRNA have been described previously (Ireland et al., 2001; Corps et al., 2006). Primers and probes for ADAMTS mRNA were designed using Primer Express (Applied Biosystems). Each ADAMTS amplicon was chosen to include exon-exon boundaries to prevent amplification of genomic DNA, and no signal was produced if either the RNA or the reverse transcriptase was omitted. BLASTn searches () revealed no significant similarity to other sequences. Each primer pair generated a single product of the appropriate size, and no signal was produced when the wrong probe was included with each primer pair, indicating an absence of cross-reactivity. Accession numbers, amplicons, forward primer (F), reverse primer (R) and probe (P) sequences were as follows:ADAMTS-1 (; 77 bp):F =CCAGTGACCGGGATGCAR =ACATGTCTGGGACCCACACAP =TATGACACAGCAATTCTTTTCACCAGACAGGACADAMTS-4 (; 83 bp):F =GCAACGTCAAGGCTCCTCTTR =CTCCACAAATCTACTCAGTGAAGCAP =AGACCCCGAAGAGCCAAGCGCTADAMTS-5 (; 73 bp):F =AGGAGCACTACGATGCAGCTATCR =CCCAGGGTGTCACATGAATGP =TGCCCACATAAATCCTCCCGAGTAAACA
###end p 44
###begin p 45
###xml 19 22 19 22 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F&#160;=</label>
###xml 22 39 22 39 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="46">CCAGTGACCGGGATGCA</p>
###xml 19 39 19 39 <list-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><label>F&#160;=</label><p textid="46">CCAGTGACCGGGATGCA</p></list-item>
###xml 39 42 39 42 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R&#160;=</label>
###xml 42 62 42 62 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="47">ACATGTCTGGGACCCACACA</p>
###xml 39 62 39 62 <list-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><label>R&#160;=</label><p textid="47">ACATGTCTGGGACCCACACA</p></list-item>
###xml 62 65 62 65 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P&#160;=</label>
###xml 65 98 65 98 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="48">TATGACACAGCAATTCTTTTCACCAGACAGGAC</p>
###xml 62 98 62 98 <list-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><label>P&#160;=</label><p textid="48">TATGACACAGCAATTCTTTTCACCAGACAGGAC</p></list-item>
###xml 19 98 19 98 <list xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" list-type="simple"><list-item><label>F&#160;=</label><p textid="46">CCAGTGACCGGGATGCA</p></list-item><list-item><label>R&#160;=</label><p textid="47">ACATGTCTGGGACCCACACA</p></list-item><list-item><label>P&#160;=</label><p textid="48">TATGACACAGCAATTCTTTTCACCAGACAGGAC</p></list-item></list>
ADAMTS-1 (; 77 bp):F =CCAGTGACCGGGATGCAR =ACATGTCTGGGACCCACACAP =TATGACACAGCAATTCTTTTCACCAGACAGGAC
###end p 45
###begin p 46
CCAGTGACCGGGATGCA
###end p 46
###begin p 47
ACATGTCTGGGACCCACACA
###end p 47
###begin p 48
TATGACACAGCAATTCTTTTCACCAGACAGGAC
###end p 48
###begin p 49
###xml 19 22 19 22 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F&#160;=</label>
###xml 22 42 22 42 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="50">GCAACGTCAAGGCTCCTCTT</p>
###xml 19 42 19 42 <list-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><label>F&#160;=</label><p textid="50">GCAACGTCAAGGCTCCTCTT</p></list-item>
###xml 42 45 42 45 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R&#160;=</label>
###xml 45 70 45 70 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="51">CTCCACAAATCTACTCAGTGAAGCA</p>
###xml 42 70 42 70 <list-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><label>R&#160;=</label><p textid="51">CTCCACAAATCTACTCAGTGAAGCA</p></list-item>
###xml 70 73 70 73 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P&#160;=</label>
###xml 73 95 73 95 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="52">AGACCCCGAAGAGCCAAGCGCT</p>
###xml 70 95 70 95 <list-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><label>P&#160;=</label><p textid="52">AGACCCCGAAGAGCCAAGCGCT</p></list-item>
###xml 19 95 19 95 <list xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" list-type="simple"><list-item><label>F&#160;=</label><p textid="50">GCAACGTCAAGGCTCCTCTT</p></list-item><list-item><label>R&#160;=</label><p textid="51">CTCCACAAATCTACTCAGTGAAGCA</p></list-item><list-item><label>P&#160;=</label><p textid="52">AGACCCCGAAGAGCCAAGCGCT</p></list-item></list>
ADAMTS-4 (; 83 bp):F =GCAACGTCAAGGCTCCTCTTR =CTCCACAAATCTACTCAGTGAAGCAP =AGACCCCGAAGAGCCAAGCGCT
###end p 49
###begin p 50
GCAACGTCAAGGCTCCTCTT
###end p 50
###begin p 51
CTCCACAAATCTACTCAGTGAAGCA
###end p 51
###begin p 52
AGACCCCGAAGAGCCAAGCGCT
###end p 52
###begin p 53
###xml 19 22 19 22 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F&#160;=</label>
###xml 22 45 22 45 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="54">AGGAGCACTACGATGCAGCTATC</p>
###xml 19 45 19 45 <list-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><label>F&#160;=</label><p textid="54">AGGAGCACTACGATGCAGCTATC</p></list-item>
###xml 45 48 45 48 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R&#160;=</label>
###xml 48 68 48 68 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="55">CCCAGGGTGTCACATGAATG</p>
###xml 45 68 45 68 <list-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><label>R&#160;=</label><p textid="55">CCCAGGGTGTCACATGAATG</p></list-item>
###xml 68 71 68 71 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P&#160;=</label>
###xml 71 99 71 99 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="56">TGCCCACATAAATCCTCCCGAGTAAACA</p>
###xml 68 99 68 99 <list-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><label>P&#160;=</label><p textid="56">TGCCCACATAAATCCTCCCGAGTAAACA</p></list-item>
###xml 19 99 19 99 <list xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" list-type="simple"><list-item><label>F&#160;=</label><p textid="54">AGGAGCACTACGATGCAGCTATC</p></list-item><list-item><label>R&#160;=</label><p textid="55">CCCAGGGTGTCACATGAATG</p></list-item><list-item><label>P&#160;=</label><p textid="56">TGCCCACATAAATCCTCCCGAGTAAACA</p></list-item></list>
ADAMTS-5 (; 73 bp):F =AGGAGCACTACGATGCAGCTATCR =CCCAGGGTGTCACATGAATGP =TGCCCACATAAATCCTCCCGAGTAAACA
###end p 53
###begin p 54
AGGAGCACTACGATGCAGCTATC
###end p 54
###begin p 55
CCCAGGGTGTCACATGAATG
###end p 55
###begin p 56
TGCCCACATAAATCCTCCCGAGTAAACA
###end p 56
###begin p 57
Standard curves were run in each assay, using freshly-diluted aliquots of pooled tendon cell or tissue RNA. For each target, this produced a linear plot of threshold cycle (Ct) against log(dilution), whose slope was within 10% of the expected value, indicating a similar, near-maximum efficiency for each target. This was confirmed by the demonstration of constant Ct differences with dilution in pairwise comparisons of each target mRNA. For each experiment, all samples of RNA were assayed in duplicate or triplicate wells on the same plate (typically 2 ng/well of total RNA for mRNA targets, and 20 pg/well of total RNA for the more abundant 18S rRNA). The values obtained for ADAMTS mRNA expression were normalised for GAPDH mRNA or 18S rRNA expression in the same sample, using the formulaand correcting for the different input RNA into the 18S rRNA assay. Values were compared against those for control cultures in the same experiment (i.e. cultures receiving the same changes of medium but incubated with vehicle rather than growth factors or cytokines) as 100%.
###end p 57
###begin title 58
Acknowledgements
###end title 58
###begin p 59
We thank Fred Robinson, Helen Birch and Tomas Movin for the provision of tendon samples. This work was supported by the Cambridge Arthritis Research Endeavour, the Arthritis Research Campaign (Project Grants R0561, R0574 and R0603), the Isaac Newton Trust and the Sybil Eastwood Memorial Trust.
###end p 59
###begin title 60
References
###end title 60
###begin article-title 61
Bone morphogenetic proteins and tendon repair
###end article-title 61
###begin article-title 62
Chronic Achilles tendinopathy. A survey of surgical and histopathologic findings
###end article-title 62
###begin article-title 63
Mechanical load stimulates expression of novel genes in vivo and in vitro in avian flexor tendon cells
###end article-title 63
###begin article-title 64
###xml 80 85 <span type="species:ncbi:9606">human</span>
Relative messenger RNA expression profiling of collagenases and aggrecanases in human articular chondrocytes in vivo and in vitro
###end article-title 64
###begin article-title 65
Fibrocartilage in tendons and ligaments-an adaptation to compressive load
###end article-title 65
###begin article-title 66
Mechanisms involved in cartilage proteoglycan catabolism
###end article-title 66
###begin article-title 67
###xml 59 64 <span type="species:ncbi:9606">human</span>
ADAMTS-8 exhibits aggrecanase activity and is expressed in human articular cartilage
###end article-title 67
###begin article-title 68
Increased expression of aggrecan and biglycan mRNA in Achilles tendinopathy
###end article-title 68
###begin article-title 69
The expression and regulation of ADAMTS-1, -4, -5, -9, and -15, and TIMP-3 by TGFbeta1 in prostate cells: relevance to the accumulation of versican
###end article-title 69
###begin article-title 70
Differences in the mechanism for high- versus moderate-density fibroblast-populated collagen lattice contraction
###end article-title 70
###begin article-title 71
Expression of transforming growth factor-beta isoforms and their receptors in chronic tendinosis
###end article-title 71
###begin article-title 72
IL-6 and its soluble receptor augment aggrecanase-mediated proteoglycan catabolism in articular cartilage
###end article-title 72
###begin article-title 73
Activation of the proteolytic activity of ADAMTS4 (aggrecanase-1) by C-terminal truncation
###end article-title 73
###begin article-title 74
Novel system for engineering bioartificial tendons and application of mechanical load
###end article-title 74
###begin article-title 75
###xml 75 79 <span type="species:ncbi:10090">mice</span>
Characterization of and osteoarthritis susceptibility in ADAMTS-4-knockout mice
###end article-title 75
###begin article-title 76
Fibroblast biology in three-dimensional collagen matrices
###end article-title 76
###begin article-title 77
Mechanism of catabolism of aggrecan by articular cartilage
###end article-title 77
###begin article-title 78
###xml 47 52 <span type="species:ncbi:9606">human</span>
Multiple changes in gene expression in chronic human Achilles tendinopathy
###end article-title 78
###begin article-title 79
Histopathological findings in chronic tendon disorders
###end article-title 79
###begin article-title 80
###xml 112 117 <span type="species:ncbi:9606">human</span>
Expression profiling of metalloproteinases and tissue inhibitors of metalloproteinases in normal and degenerate human Achilles tendon
###end article-title 80
###begin article-title 81
Histopathological changes preceding spontaneous rupture of a tendon
###end article-title 81
###begin article-title 82
Expression profiling of metalloproteinases and their inhibitors in cartilage
###end article-title 82
###begin article-title 83
###xml 71 76 <span type="species:ncbi:9606">human</span>
The modulation of matrix metalloproteinase and ADAM gene expression in human chondrocytes by interleukin-1 and oncostatin M: a time-course study using real-time quantitative reverse transcription-polymerase chain reaction
###end article-title 83
###begin article-title 84
ADAMTS-1 cleaves cartilage proteoglycan, aggrecan
###end article-title 84
###begin article-title 85
In vitro alterations in cytoskeletal tensional homeostasis control gene expression in tendon cells
###end article-title 85
###begin article-title 86
Effect of amplitude and frequency of cyclic tensile strain on the inhibition of MMP1 mRNA expression in tendon cells: an in vitro study
###end article-title 86
###begin article-title 87
Mechanical injury of cartilage explants causes specific time-dependent changes in chondrocyte gene expression
###end article-title 87
###begin article-title 88
###xml 18 22 <span type="species:ncbi:10090">mice</span>
ADAMTS-1-knockout mice do not exhibit abnormalities in aggrecan turnover in vitro or in vivo
###end article-title 88
###begin article-title 89
Light microscopic histology of Achilles tendon ruptures: a comparison with unruptured tendons
###end article-title 89
###begin article-title 90
###xml 100 105 <span type="species:ncbi:9606">human</span>
Effects of transforming growth factor-beta on aggrecanase production and proteoglycan degradtion by human chondrocytes in vitro
###end article-title 90
###begin article-title 91
Tendon pathology in long-standing achillodynia
###end article-title 91
###begin article-title 92
###xml 70 78 <span type="species:ncbi:9606">patients</span>
Expression of bone morphogenetic proteins in the subacromial bursa of patients with chronic degeneration of the rotator cuff
###end article-title 92
###begin article-title 93
###xml 108 114 <span type="species:ncbi:9913">bovine</span>
Analysis of ADAMTS4 and MT4-MMP indicates that both are involved in aggrecanolysis in interleukin-1-treated bovine cartilage
###end article-title 93
###begin article-title 94
Induction of aggrecanase 1 (ADAM-TS4) by interleukin-1 occurs through activation of constitutively produced protein
###end article-title 94
###begin article-title 95
Catabolism of aggrecan, decorin and biglycan in tendon
###end article-title 95
###begin article-title 96
The pathogenesis of tendinopathy. A molecular perspective
###end article-title 96
###begin article-title 97
###xml 22 27 <span type="species:ncbi:9606">human</span>
Glycosaminoglycans of human rotator cuff tendons: changes with age and in chronic rotator cuff tendinitis
###end article-title 97
###begin article-title 98
Matrix metalloproteinase activities and their relationship with collagen remodelling in tendon pathology
###end article-title 98
###begin article-title 99
Regional expression of mRNA for proteoglycans and collagen in tendon
###end article-title 99
###begin article-title 100
Mechanical loading and TGF-beta regulate proteoglycan synthesis in tendon
###end article-title 100
###begin article-title 101
Increased cell proliferation and associated expression of PDGFRbeta causing hypercellularity in patellar tendinosis
###end article-title 101
###begin article-title 102
Characterisation of proteoglycans and their catabolic products in tendon and explant cultures of tendon
###end article-title 102
###begin article-title 103
###xml 27 32 <span type="species:ncbi:9606">human</span>
Versican V1 proteolysis in human aorta in vivo occurs at the Glu441-Ala442 bond, a site that is cleaved by recombinant ADAMTS-1 and ADAMTS-4
###end article-title 103
###begin article-title 104
Mechanisms of TGF-beta signaling from cell membrane to the nucleus
###end article-title 104
###begin article-title 105
###xml 85 107 <span type="species:ncbi:6239">Caenorhabditis elegans</span>
Characterization of ADAMTS-9 and ADAMTS-20 as a distinct ADAMTS subfamily related to Caenorhabditis elegans GON-1
###end article-title 105
###begin article-title 106
###xml 36 41 <span type="species:ncbi:10090">mouse</span>
ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro
###end article-title 106
###begin article-title 107
ADAMTS: a novel family of extracellular matrix proteases
###end article-title 107
###begin article-title 108
The role of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) in a model of cartilage degradation
###end article-title 108
###begin article-title 109
###xml 73 78 <span type="species:ncbi:9606">human</span>
IL-1beta induces COX2, MMP-1, -3 and -13, ADAMTS-4, IL-1beta and IL-6 in human tendon cells
###end article-title 109
###begin article-title 110
Expression and activity of ADAMTS-5 in synovium
###end article-title 110
###begin article-title 111
ADAMTS-1, a gene product of articular chondrocytes in vivo and in vitro, is down-regulated by interleukin 1beta
###end article-title 111
###begin article-title 112
###xml 72 77 <span type="species:ncbi:9606">human</span>
Characterization of collagens and proteoglycans at the insertion of the human Achilles tendon
###end article-title 112
###begin article-title 113
Subcutaneous rupture of the Achilles tendon: basic science and some aspects of clinical practice
###end article-title 113
###begin article-title 114
###xml 32 37 <span type="species:ncbi:9606">human</span>
ADAMTS4 (aggrecanase-1) cleaves human brain versican V2 at Glu405-Gln406 to generate glial hyaluronate binding protein
###end article-title 114
###begin article-title 115
Expression and regulation of aggrecanase in arthritis; the role of TGF-beta
###end article-title 115
###begin p 116
###xml 266 267 266 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 283 284 278 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
ADAMTS-4 mRNA expression in normal, painful and ruptured tendon. Tendon RNA samples were analysed for ADAMTS-4 mRNA, expressed relative to 18S rRNA as outlined in the text. Each point represents an individual sample. The median values are shown (horizontal bar). ** P < 0.01, dagger P < 0.05, for differences between ruptured tendon and the normal and painful tendon groups respectively, by Wilcoxon rank sum test.
###end p 116
###begin p 117
###xml 256 260 255 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cell</italic>
###xml 328 334 324 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">arrows</italic>
ADAMTS-4 immunoreactivity in tendon tissue. Western blots of protein extracts (10 mug/lane) from 3 samples each of normal, painful and ruptured tendon tissue were probed using the ADAMTS-4-specific antibodies (A) AHP821GA and (B) PA1-1749. The lane marked cell contained extract from a TGF-beta-treated tendon cell culture. The arrows indicate the mature and processed forms of the ADAMTS proteins discussed in the text. Similar results were obtained using 3 further samples per tissue group, run on a separate pair of blots.
###end p 117
###begin p 118
###xml 671 672 642 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 684 685 655 656 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 822 823 788 789 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Regulation of ADAMTS-4 mRNA expression in cultured tendon cells by growth factors and cytokines. Tendon cells were incubated for 6, 24 or 48 h with EGF (10 ng/ml, ■), FGF (1 ng/ml, ▲), PDGF (10 ng/ml, ●), TNF (10 ng/ml, diamond), IL-1beta (1 ng/ml, square), TGF-beta (1 ng/ml, Delta) or TGF-beta plus IL-1beta (panel C, filled column). Total cell RNA was extracted and analysed for ADAMTS-4 mRNA, expressed relative to GAPDH mRNA and normalised to the value obtained for control cells at the same time-point (defined as 100% and shown as a broken line). Results are mean +/- s.e.m. from at least 4 experiments with each agonist (panels A,B) or 3 experiments (panel C); * P < 0.05, ** P < 0.01 compared with the control at the same time point, determined from 95% or 99% confidence intervals of the treated samples; dagger P < 0.05 for TGF-beta plus IL-1beta compared with either cytokine alone.
###end p 118
###begin p 119
###xml 455 456 447 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 469 470 461 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Regulation of ADAMTS-4 mRNA expression in cultured tendon cells by TGF-beta and BMP. Tendon cells were incubated for 24 h with TGF-beta or BMP-2, -7 or -13 at the concentrations shown (ng/ml). Total cell RNA was extracted and analysed for ADAMTS-4 mRNA, expressed relative to GAPDH mRNA and normalised to the mean value obtained for control cells (defined as 100%). Results shown are mean +/- s.e.m. of three wells per treatment in a single experiment; * P < 0.05, *** P < 0.001 by t-test. Similar results were obtained in a separate experiment with cells derived from a second donor.
###end p 119
###begin p 120
###xml 260 266 257 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">arrows</italic>
ADAMTS-4 protein expression in cultured tendon cells. Western blots of protein extracts from tendon cell cultures incubated for 24 h with vehicle (Con) or TGF-beta (1 ng/ml) were probed using the ADAMTS-4-specific antibodies (A) AHP821GA and (B) PA1-1749. The arrows indicate the mature (68 kDa) and processed (53 kDa) forms of ADAMTS-4 discussed in the text. Similar results were obtained in two additional experiments.
###end p 120
###begin p 121
###xml 234 240 234 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig3" ref-type="fig">Fig. 3</xref>
###xml 319 320 317 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 332 333 330 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Regulation of ADAMTS-1 and ADAMTS-5 mRNA expression in cultured tendon cells. Tendon cells were incubated with growth factors and cytokines, and total cell RNA was analysed for ADAMTS-1 or ADAMTS-5 mRNA, as described in the legend to Fig. 3. Results are mean +/- s.e.m. from at least 4 experiments with each agonist; * P < 0.05, ** P < 0.01 compared with the control at the same time point, determined from the 95% or 99% confidence intervals of the treated samples.
###end p 121
###begin p 122
###xml 634 635 626 627 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 647 648 639 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Regulation of ADAMTS-4 mRNA expression in tendon cells cultured in collagen gels. Tendon cells in monolayer cultures (open columns) or collagen gels (filled columns) were incubated for 24 h with vehicle (Con), IL-1beta (1 ng/ml), TGF-beta (1 ng/ml) or TNF (10 ng/ml). Total cell RNA was extracted and analysed for ADAMTS-4 mRNA, expressed relative to 18S rRNA and normalised to the value obtained for control cells in monolayer culture or gel respectively (defined as 100%): note that the mean control level in collagen gels was 2.6-fold higher than that in monolayer cultures. Results shown are mean +/- s.e.m. from 4 experiments; * P < 0.05, ** P < 0.01 compared with the respective control values, determined from the 95% or 99% confidence intervals of the treated samples.
###end p 122
###begin p 123
Expression of ADAMTS mRNA in tendon cells incubated for 48 h in collagen gels relative to parallel monolayer cultures
###end p 123
###begin p 124
###xml 255 256 253 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 298 299 296 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 245 253 <span type="species:ncbi:9606">patients</span>
ADAMTS or GAPDH mRNA was normalised to 18S rRNA, and the value for collagen cultures was expressed relative to that in parallel monolayer cultures of the same cells (defined as 100%). Mean +/- s.e.m. from experiments using cells from 5 separate patients. P values were determined from a one-sample t-test against a theoretical mean of 100%. ns = not significant.
###end p 124

